| Literature DB >> 28516981 |
A Lovato1, D A Restivo2, G Ottaviano3, G Marioni3, R Marchese-Ragona3.
Abstract
Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary fistulae that may have a post-traumatic or post-operative origin. BTX injections can be considered in sialoceles and salivary fistulae after the failure of or together with conservative treatments (e.g. antibiotics, pressure dressings, or serial aspirations). BTX treatment has a promising role in chronic sialadenitis. BTX therapy is highly successful in the treatment of gustatory sweating (Frey's syndrome), and could be considered the gold standard treatment for this neurological disorder. © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.Entities:
Keywords: Botulinum toxin; Chronic sialadenitis; Frey’s syndrome; Salivary fistula; Sialocele
Mesh:
Substances:
Year: 2017 PMID: 28516981 PMCID: PMC5463526 DOI: 10.14639/0392-100X-1608
Source DB: PubMed Journal: Acta Otorhinolaryngol Ital ISSN: 0392-100X Impact factor: 2.124